We’ve Got Boosters: Bloomberg Vaccine Tracker Methodology Blog
(Bloomberg) -- The Bloomberg Vaccine Tracker now has data on the Covid-19 booster doses that some countries are starting to deploy.
Over the next few weeks, data on those extra doses will begin to fill in on our global and U.S. tables. We're starting with state-by-state U.S. booster doses and information from several dozen countries, and we'll add more places as booster information becomes available in the data sources we use.
For now, data on booster doses is spotty and not always standardized, but we've talked to our data partners and expect improvements in the coming weeks.
In a few cases, the original sources of the data — typically governments — have added booster data in a lump sum. This may create one-day data dumps that skew some of our charts or create sudden increases. These will smooth out over time in our averages.
We're also making some small but related changes throughout the Bloomberg Vaccine Tracker. We're doing away with our calculated metric for “people covered” by a given number of doses administered. This was a figure based on the number of doses administered for each type of vaccine divided by the number of doses needed in order to be considered fully vaccinated.
When we rolled it out earlier this year, it was a useful way to compare vaccination levels between countries. With the introduction of boosters, the metric becomes less meaningful.
We also now have more comprehensive data on how many people have received at least one shot or a full series in countries around the world. So we're returning to a “doses per 100 people” metric in some places on the graphic, in others we'll use figures such as how many people have had at least one dose.
As always, thanks for reading and thanks for your feedback.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.